Medical Treatment of Noncicatricial Alopecia

Seminars in Cutaneous Medicine and Surgery

Volumn 25, Issue 1, 2006, Pages 51-55

  Hordinsky, Maria K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

alopecia; androgenetic; areata; effluvium; telogen

Indexed keywords

ANTIANDROGEN; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORMETHINE; CYCLOSPORIN; DAPSONE; DERMATOLOGICAL AGENT; DIPHENCYPRONE; DITHRANOL; EFALIZUMAB; FINASTERIDE; HEXYLENE GLYCOL; IMMUNOLOGIC AGENT; IRON; MACROGOL; METHISOPRINOL; MINOXIDIL; NONSTEROID ANTIINFLAMMATORY AGENT; PSORALEN; RETINOID; SALAZOSULFAPYRIDINE; SQUARIC ACID DIBUTYL ESTER; STEROID; THYMOPENTIN; TRIAMCINOLONE ACETONIDE; TRIAMCINOLONE HEXACETONIDE; UNINDEXED DRUG;

ACUTE DISEASE; AGING; ALOPECIA; ALOPECIA AREATA; ANEMIA; CANCER PREVENTION; CHRONIC DISEASE; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRY SKIN; ERYTHEMA; EXPERIMENTAL MOUSE; FEMALE ANDROGENETIC ALOPECIA; FOOD AND DRUG ADMINISTRATION; HAIR TRANSPLANTATION; HISTORY; HORMONE SUBSTITUTION; HUMAN; HYPERTRICHOSIS; IMMUNOTHERAPY; IRON THERAPY; LABORATORY TEST; MALE TYPE ALOPECIA; NONHUMAN; POSTMENOPAUSE; PREGNANCY; PROSTATE CANCER; PRURITUS; REVIEW; SCALP; SEXUAL DYSFUNCTION; SKIN ALLERGY; SKIN DISEASE; SKIN IRRITATION; STEROID THERAPY; TELOGEN EFFLUVIUM; TERATOGENESIS; TOPICAL TREATMENT; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ALOPECIA; ANDROSTENES; COSMETICS; FEMALE; HAIR; HUMANS; MALE; TREATMENT OUTCOME;

EID: 33645987261     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2006.01.007     Document Type: Review

References (24)

1. Hamilton J.B. Patterned loss of hair in man. types and incidence. Ann NY Acad Sci 53 (1951) 708-728
2. Norwood O. Male pattern baldness. Classification and incidence. South Med J 68 (1975) 1359-1365
3. Koperski J.A., Orenberg E.K., and Wilkinson D.I. Topical minoxidil therapy for androgenetic alopecia. A 30-month study. Arch Dermatol 123 (1987) 1483-1487
4. Rietschel R.L., and Duncan S.H. Safety and efficacy of topical minoxidil in the management of androgenetic alopecia. J Am Acad Dermatol 16 (1987) 677-685
5. Kaufman K.D., Olsen E.A., Whiting D., et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 39 (1998) 578-589
6. Leyden J., Dunlap F., Miller B., et al. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol 40 (1999) 930-937
7. Walsh D.S., Dunn C.L., and James W.D. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride. Arch Dermatol 131 (1995) 1373-1375
8. Arca E., Acikgoz G., Tastan H.B., et al. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Dermatology 209 (2004) 117
9. Thompson I.M., Goodman P.J., Tangen C.M., et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 349 (2003) 215
10. Rosner W. Proscar and Propecia-a therapeutic perspective. J Clin Endocrinol Metab 89 (2004) 3096
11. Ludwig E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 97 (1977) 247-254
12. Olsen E.A. Pattern hair loss in men and women. In: Olsen E. (Ed). Disorders of Hair Growth (2003), McGraw-Hill, New York, NY
13. Olsen E.A., Messenger A.G., Shapiro J., et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 52 (2005) 301-311
14. Knochenhauer E., and Azziz R. Ovarian hormones and adrenal androgens during a woman's life span. J Am Acad Dermatol 45 (2001) S105-S115
15. Lucky A.W., Piacquadio D.J., Ditre C.M., et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of female pattern hair loss. J Am Acad Dermatol 50 (2004) 541
16. Price V.H., Roberts J.L., Hordinsky M.H., et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol 43 (2000) 768-776
17. Scheman A.J., West D.P., Hordinsky M.H., et al. Alternative formulation for patients with contact reactions to topical 2% and 5% minoxidil vehicle ingredients. Contact Dermatitis 42 (2000) 241
18. Oro A.E., and Higgins K. Hair cycle regulation of Hedgehog signal reception. Dev Biol 255 (2003) 238-248
19. Headington J.T. Telogen effluvium. Arch Dermatol 129 (1993) 356-363
20. Whiting D.A. Chronic telogen effluvium. increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 35 (1996) 899-906
21. Kantor J., Kessler L.J., Brooks D.G., et al. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 121 (2003) 985-988
22. Hordinsky M. Alopecia Areata. In: Olsen E. (Ed). Disorders of Hair Growth (2003), McGraw-Hill, New York, New York
23. Bolduc C., and Shapiro J. The treatment of alopecia areata. Dermatol Ther 14 (2001) 306-316
24. Price V.H. Treatment of hair loss. N Engl J Med 341 (1999) 964